Type 2 Diabetes - Pharma

Relevant Publications

Dietary Amino Acids Promote Glucagon-like Hormone Release to Generate Novel Calcium Waves in Adipose Tissues.

Issue Release: 2024

LIVERSTAT for risk stratification for patients with metabolic dysfunction-associated fatty liver disease.

Issue Release: 2024

Systemic Deletion of ARRDC4 Improves Cardiac Reserve and Exercise Capacity in Diabetes.

Issue Release: 2024

Chronic Kidney Disease Study in Diabetic Patients: Insights From Primary Care Units in Northern Portugal.

Issue Release: 2024

Evaluating Yoga-Based Intervention Versus the American Diabetes Association Exercise Regimen in Conjunction With Standard Care for Autonomic Neuropathy in Diabetes Mellitus: An Exploratory Clinical Trial.

Issue Release: 2024

Advances in the treatment of type 2 diabetes mellitus by natural plant polysaccharides through regulation of gut microbiota and metabolism: A review.

Issue Release: 2024

Correction: The Regulate your Sitting Time (RESIT) intervention for reducing sitting time in individuals with type 2 diabetes: findings from a randomised-controlled feasibility trial.

Issue Release: 2024

Serum L C3-II levels in type 2 diabetic patients with impaired renal functions.

Issue Release: 2024

Application of anti-vascular endothelial growth factor antibody restores the function of saliva secretion in a type 2 diabetes mouse model.

Issue Release: 2024

Sodium Tungstate (NaW) Decreases Inflammation and Renal Fibrosis in Diabetic Nephropathy.

Issue Release: 2024

Cross-sectional and longitudinal associations among healthcare costs and deficit accumulation.

Issue Release: 2024

The signaling pathways in obesity-related complications.

Issue Release: 2024

Impact of glucagon-like peptide receptor agonists on endoscopy and its preoperative management: Guidelines, challenges, and future directions.

Issue Release: 2024

The Gene Expression Landscape of Disease Genes.

Issue Release: 2024

Behavioral Engagement and Activation Model Study (BEAMS): A latent class analysis of adopters and non-adopters of digital health technologies among people with Type 2 diabetes.

Issue Release: 2024

Gender-Affirming Hormone Treatment and Metabolic Syndrome Among Transgender Veterans.

Issue Release: 2024

Thrombospondin-1 promotes fibro-adipogenic stromal expansion and contractile dysfunction of the diaphragm in obesity.

Issue Release: 2024

Pharmacotherapeutic options for metabolic dysfunction-associated steatotic liver disease: where are we today?

Issue Release: 2024

Albuminuria and chronic kidney disease progression in patients with type 2 diabetes mellitus.

Issue Release: 2024

Biomarker for cardiorenal syndrome risk in patients with liver cirrhosis and type 2 diabetes in Saudi Arabia.

Issue Release: 2024

Why is Generic Competition Important?

Who are Pharmacists?

What is the Future of the Pharmacy Profession?

Why do Pharma Companies Use CROs?

Why are Collaborative Care Models Important in Pharma?

What is Cellular Stress?

What is a New Drug Application (NDA)?

What Are Clinical Trials?

What are the Implications for Pharma Companies?

How Does Pharma Play a Role in Chronic Conditions?

Partnered Content Networks

Relevant Topics